Vagulienė, Neringa. 2020. “THE PEMBREIZH MULTICENTER REAL-LIFE COHORT STUDY: FIRST LINE PEMBROLIZUMAB FOR NON-SMALL CELL LUNG CANCER PATIENTS WITH PD-L1 ≥50%”. Pulmonology and Allergology 4 (2), 164-67. https://doi.org/10.37499/PIA.119.